Digital Media Campaign for Tobacco Use Prevention (DMCC Trial)

N/A

Recruiting

Research Sponsored by George Washington University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Young adults age 18-24 who are members of the Ipsos/Knowledge Panel

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up ad awareness outcome (aim 1): by the end of year 1, vaping & smoking outcome (aim 2): by the end of year 5

Awards & highlights

No Placebo-Only Group

Summary

This trial will examine the effects of online anti-tobacco messages on young people's attitudes, beliefs, and behaviors related to tobacco use.

Who is the study for?

This trial is for young adults aged 18-24 who are part of the Ipsos/Knowledge Panel. It's designed to evaluate if digital ads can influence anti-tobacco attitudes and behaviors. People outside this age group or not in the panel cannot participate.

What is being tested?

The study tests the impact of different levels of exposure to anti-vaping and anti-smoking digital advertising on youth and young adult attitudes, beliefs, or actions against tobacco use through online experiments and field evaluations.

What are the potential side effects?

Since this trial involves exposure to digital media campaigns rather than medical treatments, traditional side effects are not applicable. However, participants may experience changes in perception towards tobacco use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am aged 18-24 and a member of the Ipsos/Knowledge Panel.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ ad awareness outcome (aim 1): by the end of year 1, vaping & smoking outcome (aim 2): by the end of year 5

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~ad awareness outcome (aim 1): by the end of year 1, vaping & smoking outcome (aim 2): by the end of year 5

This trial's timeline: 3 weeks for screening, Varies for treatment, and ad awareness outcome (aim 1): by the end of year 1, vaping & smoking outcome (aim 2): by the end of year 5 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

30-day use of electronic cigarettes (vaping)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Digital interventionExperimental Treatment1 Intervention

Participants will be randomized to receive variable levels of exposure (including no exposure control) of digital anti-vaping and anti-smoking messages. We will evaluate the effects of experimental condition and exposure on outcomes (tobacco product use).

Group II: ControlActive Control1 Intervention

No exposure control condition

0 / 1Eligibility criteria met